However, when addressing familial BC in carriers of BRCA1 and BRCA2 mutations, a distinct approach is required, emphasizing developmental influences persisting over the individual’s lifespan and continuously impacting the affected cells. This evidence concerns the gene BRCA2 and breast cancer.